Molecular Braille: A Novel Technology for Identification and Characterization of Compounds that Modulate Receptor Function

11/3/1999

Click here to start

Table of Contents

Molecular Braille: A Novel Technology for Identification and Characterization of Compounds that Modulate Receptor Function

PPT Slide

Molecular Braille

Example: The Estrogen Receptor

PPT Slide

PPT Slide

Step 1: Peptide Isolation

PPT Slide

PPT Slide

Step 2: Peptide Validation

Peptide Validation: Two-Hybrid Analysis of Peptides to Verify Intracellular Binding

Peptides interact the same in cells and in vitro

Peptide Validation: The peptides disrupt ER/ERE mediated transcription

The a II, a/b III, and a/b V peptides inhibit tamoxifen partial agonist activity

Step 3: High Throughput Screening

A novel ER modulator identified during a peptide competition screen

NPC-0300 effects peptide binding to ER a with other compounds present

NPC-0300 effects peptide binding to ER b with other compounds present

Step 4: Compound Characterization and Optimization

Determination of a quantitative braille pattern

Compound Fingerprints with ER-a

Compound Fingerprints with ER-b

Summary

Notes

Author: Dale J. Christensen

Email: [email protected]

Home Page: http://www.novalon.com

Download presentation source

Back to the Meeting Presentations page
Back to The Laboratory Robotics Interest Group homepage at https://www.lab-robotics.org